FDA Brief

Warning letters Drugs

FDA warning letter to

Filler Lux dba Filler Lux USA

High riskIssued Mar 3, 2025Posted Mar 11, 2025Center for Drug Evaluation and Research (CDER)

FDA warned Filler Lux USA that it sells unapproved injectable lipolytic drugs online without FDA approval.

What happened

FDA reviewed fillerx.com in December 2024 and an Instagram page that directs consumers to it, and found injectable lipolytic products offered for sale with claims to dissolve fat and affect body structure. FDA said the products are drugs and new drugs without approved applications.

What FDA found

  1. The website sells injectable lipolytic products with claims that they dissolve fat or affect body structure, so FDA treats them as drugs.

    21 U.S.C. 321(g)(1)
  2. The products are new drugs because FDA does not generally recognize them as safe and effective for those uses.

    21 U.S.C. 321(p)
  3. The company introduced or delivered the products for interstate commerce without an FDA-approved drug application.

    21 U.S.C. 355(a); 21 U.S.C. 331(d)
  4. No approved applications under section 505 are in effect for these products.

    21 U.S.C. 355

What FDA wants

FDA asks the company to notify it in writing within 15 working days of steps taken to correct the violations and prevent recurrence, with supporting documents. If the company disagrees, it must explain why and provide support; if it cannot finish, it must give the reason and completion date.

Who should pay attention

  • clinics and med spas buying injectable fat-dissolving products
  • online retailers and distributors of aesthetic injectables
  • consumers considering unapproved injectable lipolytic products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk